Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Vasopressin: a new target for the treatment of heart failure
HTML
Details
Locations
Year:
2003
Type:
review
Source:
American Heart Journal
DOI:
10.1016/s0002-8703(02)94708-3
Authors:
Craig R Lee,
Michael L Watkins,
J.Herbert Patterson,
Wendy Gattis,
Christopher M O’Connor,
Mihai Gheorghiade,
Kirkwood F Adams
show all 7
Institutions:
University of North Carolina at Chapel Hill,
Duke Clinical Research Institute,
Northwestern University
Language:
English
Topic:
Electrolyte and hormonal disorders
Subfield:
Nephrology
Field:
Medicine
Domain:
Health Sciences
Keywords:
vasopressin,
vasopressin receptor antagonists,
heart failure,
V1a receptor,
V2 receptor,
tolvaptan,
conivaptan,
hyponatremia,
fluid overload,
cardiac remodeling,
sodium excretion,
pulmonary capillary wedge pressure,
angiotensin II,
norepinephrine,
plasma osmolality
show all 15
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2085119936
FWCI:
2.958
Cites:
52
Cited by:
222
Related to:
10